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A B S T R A C T
Mulberry leaves, a traditional Chinese medicine, are effective in the treatment of diabetes 
mellitus. Rutin and quercetin are the main components of total flavones of mulberry 
leaf extract. To study the pharmacokinetics of rutin and quercetin in rat plasma and 
their metabolites in rat urine and feces after oral administration of total flavones of 
mulberry leaf extract. At different timepoints after oral administration of total flavones 
of mulberry leaf extract in rats, plasma concentrations of rutin and quercetin were 
determined by RP-HPLC. The main pharmacokinetic parameters were estimated using 
3P97 software. The metabolites in rat urine and feces were determined by using UPLC-
ESI-QTOF/MS and estimated MetaboLynxTM software. The plasma concentration-time 
curves of rutin and quercetin both were best fitted with a two-compartment model. 
Rutin and quercetin were absorbed rapidly and then slowly decreased. Two prototype 
compounds and seven metabolites were identiﬁed. The pharmacokinetic and metabolic 
results may be useful for further studies of the bioactive mechanism of mulberry leaf 
flavones and potential development of a new TCM. 
© 2013 Elsevier Editora Ltda. 
Original Article
Pharmacokinetic study of rutin and quercetin in rats after 
oral administration of total flavones of mulberry leaf extract
Zhen Ou-yanga,*, Xu Caoa, Yuan Weia, Wei-Wan-Qi Zhanga, Ming Zhaoa, Jin-ao Duanb
aSchool of Pharmacy, Jiangsu University, Zhenjiang, PR, China
bJiangsu Key Laboratory for Traditional Chinese Medicine Formulae Research, Nanjing University of Chinese Medicine, Nanjing, PR, China
Introduction
Mulberry leaves (Morus alba L., Moraceae) have been 
cultivated in many Asian countries including China, Korea, 
Japan and Thailand. The infusion of its leaves is consumed 
as antihyperglycemic nutraceutical foods for patients with 
diabetes mellitus. Scientific and clinical studies have confirmed 
that mulberry leaves have a good hypoglycemic effect (Yang et 
al., 2007; Sun et al., 2002). Flavones are the main constituents 
of hypoglycemic mulberry leaves. Those flavones mainly 
contain rutin (1), quercetin (2), kaempferol-3-O-rutinose and 
kaempferol. Rutin and quercetin in mulberry leaves  inhibit 
could  enhance antioxidative activity and hyperglycemia (Ana 
et al., 2010; Mahmood et al., 2003; Yang et al., 2008; Jo S-H et al., 
2010). The pharmacokinetics of pure rutin and quercetin has 
been studied, but not specifically in the mulberry leaf extract. 
In this study we used a reliable reversed phase high 
performance liquid chromatography (RP-HPLC) method for 
the simultaneous determination of two active components, 
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In the metabolism study, an AcQuity UPLCTM BEH C18 
column (1.7 μm, 100 mm × 2.1 mm) (Waters, Milford, MA, 
USA) was used for the analysis. The column temperature 
was maintained at 30 °C. The standards and extracts were 
analyzed by UPLC chromatography using a gradient mobile 
phase consisting of the water solvent A and ACN as solvent 
B. The gradient  of the mobile phase conditions were: 0 
min 95% A, 5.0 min 90% A, 8.0 min 88% A, 10.0 min 85% A, 
15.0 min 85% A, 18.0 min 45% A, and 20.0 min 10% A. The 
ﬂow rate was 0.40 ml·min-1. The mobile phase was passed 
through a 0.22 μm Millipore ﬁlter. The injection volume was 
2 μl. 
In the metabolism study, the negative ion mode was used 
to analyze metabolites in rat urine and feces samples. For 
analysis, the electrospray source parameters were ﬁxed as 
follows: electrospray capillary voltage was 4.0 kV for positive 
ionization mode and 3.0 kV for negative ionization mode; 
source temperature was 100 °C and desolvation temperature 
was 250 °C. The cone voltage was 30 V. set at Nitrogen was 
used the cone and collision gases. The cone and desolvation 
gas ﬂows were 50 and 700 l·h-1, respectively. The collision 
energy trap Collision energy (CE) was set at 6.0 eV and the 
transfer was CE set at 4.0 eV. The mass was   set range from 
100 to 1000 m/z. 
Preparation of mulberry leaf flavones
Components were extracted from dry mulberry leaf powder 
(approximately 3 kg) using 10 l of water decocted at 80 °C for 
1 h. The ﬁltrates were collected and the residues were then 
reﬂuxed twice at 80 °C in 10 l of water for 1 h. All ﬁltrates 
were combined. The solvent was removed below 70 °C to 
obtain a certain volume at a density ratio of 1.15; 95% ethanol 
was added to the extract ﬁltrates until the concentration of 
ethanol was adjusted to 50% and centrifuged at 865 g ·min-1 
for 10 min to remove insoluble substances. The supernatant 
was separated by elution with 60% ethanol from macroporous 
adsorptive resins. The fraction was freeze-dried for 48 h. 
Mulberry leaf flavones were obtained. The content of rutin 
(1) and quercetin (2) in total flavones of mulberry leaf extract 
was determined simultaneously by HPLC as 8.714 mg·g-1 and 
2.782 mg·g-1. 
Animals
The animal protocols were approved by the Animal Care and 
Use Committee of Jiangsu University, and all experiments 
animals were conducted according to the guidelines of Jiangsu 
University. 
Male Sprague-Dawley (SD) rats (240-260 g) were purchased 
from the Laboratory Animal Service Center of the JiangSu 
University (China). The rats were maintained in an air-
conditioned animals quarter at a temperature of 22 ± 2 °C and 
a relative humidity of 50 ± 10 %. Food and water were allowed 
ad libitum. The animals were acclimatized to the facilities for 
five days, and then fasted with free access to water for 12 h 
prior to the experiment. 
rutin and quercetin, in rat plasma after oral administration of 
total flavones of mulberry leaf extract. The pharmacokinetics 
of rutin and quercetin in plasma were investigated. 
Ultra performance liquid chromatography-electrospray 
ionization quadrupole time-of-flight mass spectrometry 
(UPLC-ESI-QTOF/MS) is a reliable method for detailed chemical 
analysis. High selectivity and sensitivity characteristics have 
allowed the wide application of UPLC-ESI-QTOF/MS for 
quantitative and qualitative analyses, and metabolite analysis 
and bioassays of identiﬁcation from complex samples such 
as traditional Chinese medicines (TCM). We developed a 
method to analyze and UPLC-ESI-QTOF/MS identify potential 
metabolites in rat urine and feces following oral administration 
of total flavones of mulberry leaf extract (Zhang et al., 2003; 
Bateman et al., 2007; Zhu et al., 2006; Tiller et al., 2008). 
Materials and methods
Materials and reagents
Rutin (1) and quercetin (2) were obtained from the National 
Institute for the Control of Pharmaceutical and Biological 
Products (Beijing, China). HPLC-grade methanol was used 
for analysis and purchased from Jiangsu Hanbon Science & 
Technology CO., Ltd (Jiangsu, China); HPLC-grade acetonitrile 
(ACN) was used for analysis and purchased from Tedia 
(Fairﬁeld, OH, USA). All other reagents were of analytical grade. 
Water for UPLC analysis was puriﬁed using the Millipore water 
puriﬁcation system (Millipore, Milford, MA, USA) and ﬁltered 
with 0.22 μm membranes. Distilled water was used to extract 
and prepare samples. The mulberry leaves (Morus alba L.) used 
in this study were cultivated in Dongtai (Dongtai, Jiangsu, 
China). All samples were identified to be authentic  leaves of 
Morus alba L.,Moraceae, by teacher  Zhen Ouyang (School of 
Pharmacy, Jiangsu University, Zhenjiang, China). Samples were 
dried below 40 °C and then crushed into fine powder.
Instrumentation and analytical conditions
The HPLC system (LC-1500, JASCO, Japan) consisted of a 
pump (PU-1580 HPLC pump, JASCO, Japan), and a ultra-violet 
(UV) detector (UV-1575 Spectrometer, JASCO, Japan). The 
UPLC-ESI-QTOF/MS system consisted of an AcQuityTM ultra 
performance liquid chromatograph and an AcQuity Synapt 
mass spectrometer equipped with an electrospray ionization 
(ESI) source (Waters, Milford, MA, USA). An AcQuity Binary 
Solvent Manager system and an auto-sampler were used for 
the analysis UPLC-ESI-QTOF/MS. Date was performed with 
MassLynx V4.1 software (Waters, USA). 
In the pharmacokinetic study, the C18 column (250 mm × 
4.6 mm, 5 μm, Kromasil, HanBang, China) was used for the 
analysis. The column temperature was maintained at 30 °C 
with methanol (A) and water (0.5% acetic acid, B) as mobile 
phase (30:70, v/v) at a rate of 1 ml·min-1, the UV detection 
wavelength was at 368 nm and the column temperature was 
maintained 30 °C. The injection volume was 20 μl. The mobile 
phase was ﬁltered through to 0.45 μm Millipore ﬁlter and 
degassed before use. 
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Preparation of standard solutions, calibration standards and 
quality samples:
The stock solutions of rutin and quercetin were prepared in 
methanol. A series of standard solutions were obtained by 
diluting the mixture of the stock standard solutions with the 
mobile phase solution. 
Calibration standards of the ﬂavones mixture were prepared 
by spiking the appropriate amount of the standard solutions 
into 100 μL drug-free rat plasma to give nominal concentration 
range of 0.1664 - 8.320 μg·ml−1 for rutin (1), 0.1528 - 7.640 
μg·ml−1 for quercetin (2). 
Quality control (QC) samples were prepared at low, medium 
and high concentrations (0.2080 μg·ml−1, 1.664 μg·ml−1, 4.160 
μg·ml−1 for rutin (1) and 0.1910 μg·ml−1, 1.528 μg·ml−1, 3.820 
μg·ml−1 for quercetin (2) in the same manner to the calibration 
standards. 
Application to pharmacokinetic study in rat 
plasma and metabolites study in rat urine, feces
The rats were administered total flavones of mulberry leaf 
extract oral route at the dose of 4.0 g·kg−1 (approximately 
34.856 mg·kg−1 rutin, 11.128 mg·kg−1 quercetin). For the 
pharmacokinetic study, blood samples (500 ml) were collected 
from five rats from the fossa vein orbitalis at 0.167, 0.333, 
0.5, 0.75, 1, 1.5, 2, 3, 4, 6, 8, 12 and 24 h after dosing. Blood 
samples were immediately transferred to heparinize tubes and 
centrifuged at 1538 g for 10 min. Plasma was collected and 
then frozen at -20 °C. For the metabolism study, urine and 
feces samples were collected at the same time between 0 to 
24 h using the metabolic cage. Samples were stored at -20 °C 
until analysis. 
Pretreatment of plasma, urine and feces samples
Plasma samples of 100 μl were added to 200 μl ACN/acetic acid 
100:5 (v/v). Each tube was mixed thoroughly using a vortex 
mixer for 3 min and centrifuged at 13839 g for 10 min. The 
supernatant liquid was collected for the HPLC analysis. 
Urine samples of 500 μl were added to 1 ml of ACN. Each 
tube was mixed thoroughly using a vortex mixer for 3 min and 
centrifuged at 13839 g for 10 min. The supernatant liquid was 
collected for the analysis UPLC-ESI-QTOF/MS. 
Dried feces samples of 1 g were added to 5 ml of 70% ACN 
and dissolved using ultrasound for 10 min. The mixture was 
centrifuged at 13839 g for 10 min at 4 °C and the supernatant 
was collected for the analysis UPLC-ESI-QTOF/MS. 
Data analysis
The plasma concentration of the analytes at different 
time points were expressed mean ± SD and the mean 
concentration-time curves were plotted. Dates were 
processed using 3P97 software. The area under the plasma 
concentration-time curve (AUC), the maximum concentration 
in plasma (Cmax) and the corresponding time (tmax), the half-
life of absorption (t1/2Κa), the half-life of distribution (t1/2α) 
and the half-life of eliminate (t1/2β) were determined. All 
results were expressed as arithmetic mean ± SD. Samples 
were analyzed by QTOF/MS. The post-acquisition data were 
processed using MetaboLynxTM. 
Results and discussion
In vivo pharmacokinetic study of rutin and quercetin in rat 
plasma
Selectivity
The selectivity of the method was tested by comparing the 
chromatograms of blank plasma, spiked plasma and actual 
plasma samples after orally administered total flavones of 
mulberry leaf extract at a dose of 4.0 g·kg-1. Analytes were 
well separated and no interferences were detected from 
endogenous substances. 
Linearity, limits of detection and quantiﬁcation
The linear regression of the investigated ﬂavones in 
rat plasma was constructed by plotting peak area with 
concentration of standard solutions. The calibration curves 
showed good linearity over the concentration range 0.1664 
- 8.320 μg·ml−1 for rutin with a correlation coefﬁcient (R2) 
larger than 0.9981, and 0.1528 - 7.640 μg·ml−1 for quercetin 
with R2 larger than 0.9981. The mean standard curves 
were typically described by the equations: Y = 7327.9 X 
+ 900.75 for rutin and Y = 7982.5 X + 145.32 for quercetin. 
The limits of detection (LOD, S/N = 3) and the lower limit 
of quantiﬁcation (LLOQ, S/N = 9) were 0.0555 μg·ml−1 and 
0.1664 μg·ml−1 for rutin and  0.0509 μg·ml−1 and 0.1528 
μg·ml−1 for quercetin. 
Accuracy and precision:
The method’s precision was assessed by determination of QC 
samples (n = 6) on three different validation days. Intra-day 
precision was determined by assaying standard solutions of 
the analyte at different times during the same day. Inter-day 
precision was determined by assaying standard solutions of 
the analyte over three consecutive days. The concentration 
of each sample was determined using a calibration curve 
prepared each day Table 1.
Extraction recovery
The mean extraction recoveries of rutin from rat plasma 
at concentrations of 0.2080, 1.664 and 4.160 μg·ml-1 were 
80.6, 88.4 and 85.5%, respectively. The mean extraction 
recoveries of quercetin from rat plasma at concentrations 
of 0.1910, 1.528 and 3.820 μg·ml-1 were 79.1, 80.8 and 81.2 %, 
respectively. 
Stability
The stabilities of 0.2080, 1.664 and 4.160 μg·ml-1 rutin, or 0.1910, 
1.528 and 3.820 μg·ml-1 quercetin in rat plasma were tested 
in room temperature for 12 h, 4 °C for 24 h and -20 °C for one 
week. No significant degradation of rutin (1) or quercetin (2) 
was detected under any of these conditions (Table 2). 
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Pharmacokinetics study
The mean plasma concentration-time proﬁles of the 
investigated components were shown in Figure 1, 
demonstrating that the concentration-time proﬁle was best 
described by the two-compartment model for rutin (1) and 
quercetin (2).The pharmacokinetics and model parameters 
were calculated by the  practical pharmacokinetic program 
3P97 software.The pharmacokinetic parameters showed that 
rutin was  fastly absorbed after oral administration of  total 
flavones of mulberry leaves, the Cmax of rutin in rat plasma 
was 1.546 ± 0.188 mg·l-1, and the Tmax was 1 h. Quercetin was 
absorbed fastly also in rat, but  it has the second Cmax. The 
Cmax of quercetin in rat plasma was 1.127 ± 0.329 mg·l-1 and 
the Tmax was 0.333 h. It had a secondary absorption peak at 
6 h.There might be two reasons: the quercetin has a second 
absorption in the intestines; rutin was hydrolyzed in the 
intestinal tract. The main pharmacokinetics parameters were 
summarized in Table 3. 
Table 1 

















0.208 0.201 ± 0.007 96.6 3.48 0.197 ± 0.008 94.7 4.06
1.664 1.651 ± 0.037 99.2 2.25 1.644 ± 0.040 98.8 2.43
4.160 3.970 ± 0.086 95.4 2.16 3.920 ± 0.091 94.2 2.32
quercetin
0.191 0.184 ± 0.004 96.3 1.98 0.181 ± 0.006 94.8 3.31
1.528 1.489 ± 0.026 97.4 1.77 1.481 ± 0.029 96.9 1.96
3.820 3.700 ± 0.056 96.9 1.52 3.650 ± 0.067 95.5 1.84
Table 3
Pharmacokinetic parameters for rutin and quercetin after 
oral administration of total flavones of mulberry leaf 
extract in SD rats (at a dose containing 34.856 mg·kg-1 
rutin and 11.128 mg·kg-1 quercetin).
Parameter Rutin Quercetin
t1/2α/h 0.619 ± 0.127 0.092 ± 0.043
t1/2β/h 10.355 ± 7.339 36.454 ± 14.08
t1/2ka/h 0.358 ± 0.089 0.040 ± 0.030
AUC /mg·h·l-1 9.947 ± 2.705 5.623 ± 3.183
Tmax/h 1 0.333
Cmax/mg·l
-1 1.546 ± 0.188 1.127 ± 0.329
Table 2 
Stability of rutin and quercetin in rat plasma (n = 5, mean ± SD).
Nominal conc. 
(μg·l-1)
RT for 24 h
Conc. (μg·l-1) and RSD (%)
4 °C for 72 h
Conc. (μg·l-1) and RSD (%)
-20 °C for 2 week
Conc. (μg·l-1) and RSD (%)
rutin
0.832 0.833 ± 0.039 4.7 0.825 ± 0.044 5.3 0.823 ± 0.048 5.8
1.664 1.651 ± 0.064 3.9 1.642 ± 0.084 5.1 1.636 ± 0.075 4.6
4.160 4.013 ± 0.128 3.2 3.971 ± 0.131 3.3 3.923 ± 0.149 3.8
quercetin
0.764 0.757 ± 0.035 4.6 0.748 ± 0.028 3.7 0.744 ± 0.040 5.4
1.528 1.495 ± 0.063 4.2 1.474 ± 0.075 5.1 1.481 ± 0.076 5.1
3.820 3.759 ± 0.105 2.8 3.687 ± 0.159 4.3 3.713 ± 0.167 4.5
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Fig. 1 - UPLC-ESI-QTOF/MS total ion current chromatograms in negative ion mode of urine and feces samples after oral 
administration of mulberry leaf flavones (a, blank urine; b, urine sample; c, blank feces; d, feces sample; e, rutin and quercetin).
UPLC-QTOF-MS analysis and identiﬁcation of metabolite 
components in rat urine and feces
Data analysis
Gradient reversed phase UPLC with absorbance detection and 
dependent full scan MS date were used to analyze and identify 
the absorption and metabolic components in rat urine and feces 
after oral administration of total flavones of mulberry leaf extract. 
Fig. 2 - A. Mean concentration-time profiles of rutin and quercetin in rats after oral administration of mulberry leaf flavones 
(each point represents the mean ± S.D., n = 5; at a dose containing 34.856 mg·kg-1 rutin and 11.128 mg·kg-1 quercetin); B. semi-log 
plot of mean plasma concentration of rutin and quercetin in rats after oral administration of mulberry leaf flavones.
Urine and feces collected 0-24 h after ingestion of mulberry leaf 
flavones, and urine and feces samples were analyzed by UPLC-
ESI-QTOF/MS. The total ion current chromatograms detected in 
the negative ion mode were shown in Figure 2.
By comparing the peak retention time (tR) values and the 
MS ion fragments characteristics with reference compounds 
and published date, different classes of metabolites were 
summarized in Table 4.
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Quercetin (2) (M1): The urine and feces of three rats contained 
traces of aglycone, quercetin which had a [M-H]- at m/z 301 and 
MS fragment ions at m/z 179 and 151 in the negative ion mode. 
Rutin (1) (M2): The urine and feces of three rats contained 
traces of the rutin which had a [M-H]- at m/z 609 and MS 
fragment ions at m/z 463 and 301 in the negative ion mode.
 
Methylated quercetin (M3): In the negative ion mode at 12.28 
min, there was a [M-H]- at m/z 315 with a major ion at m/z 301 
([M-H]- - 14) in rat urine. According to mass spectrometry (MS) 
date, the compound at 12.28 min was identiﬁed as methylated 
quercetin; however, methylated quercetin was not identified 
in rat feces. 
Methylated rutin (M4): In the negative ion mode at 9.01 min, 
there was a [M-H]- at m/z 623 with a major ion at m/z 609 
([M-H]- - 14) in rat urine and feces. According to MS date, the 
compound at 9.01 min was identiﬁed as methylated rutin. 
Quercetin sulfates (M5): In the negative ion mode at 6.83 min, 
there was a [M-H]- at m/z 381 with a major ion at m/z 301 
([M-H]- - 80) in rat feces. According to MS/MS date, the 
compound at 6.83 min was identiﬁed as quercetin sulfate; 
however, quercetin sulfate was not identified in rat urine. 
Rutin sulfates (M6): In the negative ion mode at 5.93 min, there 
was a [M-H]- at m/z 689 with a major ion at m/z 609 ([M-H]- - 80) 
in rat urine and feces. According to MS date, the compound at 
5.93 min was identiﬁed as rutin sulfate. 
Quercetin glucuronide (M7): In the negative ion mode at 7.51 
min, there was a [M-H]- at m/z 477 with a major ion at m/z 301 
([M-H]- - 176) in rat urine. According to MS date, the compound 
at 7.51 min was identiﬁed as quercetin glucuronide; however, 
quercetin glucuronide was not identified in rat feces. 
Rutin glucuronide (M8): In the negative ion mode at 6.22 min, 
there was a [M-H]- at m/z 785 with a major ion at m/z 609 
([M-H]- - 176) in rat urine and feces. According to MS date, the 
compound at 6.22 min was identiﬁed as rutin glucuronide. 
Quercetin diglucuronides (M9): One diglucuronide quercetin was 
detected at 4.13 min in three rats urine during 0-24 h. The date 
indicated that two glucuronyl units were attached at different 
positions on the quercetin skeleton. Disaccharides conjugate 
fragments with the loss of the intact disaccharide moiety. If 
these two glucuronyl units had been attached at the same 
position, it is unlikely that an M-176 fragment would have been 
produced at m/z 477.
Possible metabolic pathway of rutin and quercetin after oral 
administration of mulberry leaf flavones 
In this study, the mulberry leaf flavones quercetin and rutin, 
and their potential metabolites, were analyzed. Our date 
provider guidance for studying the absorption and metabolism 
of complex active components of TCM. The presumed 
metabolic pathway including phase I and II is shown in 
Scheme 1. 
In this study we developed and validated a RP-HPLC method 
for simultaneous determination of two ﬂavones, including 
quercetin and rutin, in rat plasma after oral administration 
of the mulberry leaf flavones. We also developed the UPLC 
coupled with the QTOF-MS method for the analysis and 
identiﬁcation of potential metabolites in rat urine and feces. 
In this experiment,two components and seven metabolites 
were identiﬁed. Notably, the new metabolite, di-glucuronide 
conjugation of compound quercetin (M9) was observed. The 
pharmacokinetic and metabolic results may be useful for 
further study of the bioactive mechanism of mulberry leaf 
flavones and potential development of a new TCM. 
Table 4
Reviewed metabolite summary for quercetin and rutin by Metabolynx software.
Nº tR/min Molecular weight Metabolite Formula Mass difference Source
M1 10.90 302.0427 A: Parent C15H10O7 -0.0125 Urine, feces
M2 6.98 610.1534 B: Parent C27H30O16 0.0080 Urine, feces
M3 12.28 316.0583 A+CH2 C16H12O7 14.0067 Urine
M4 9.01 624.1690 B+CH2 C28H32O16 14.0216 Urine, feces
M5 6.83 381.9995 A+SO3 C15H10O10S 79.9699 Feces
M6 5.93 690.1102 B+SO3 C27H30O19S 79.9651 Urine, feces
M7 7.51 478.0747 A+C6H8O6 C21H18O13 176.0172 Urine
M8 6.22 786.1855 B+C6H8O6 C33H38O22 176.0369 Urine, feces
M9 4.13 654.1068 A+2C6H8O6 C27H26O19 352.0678 Urine
A, quercetin; B, rutin.
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